PO-1050: SBRT in liver cancer versus TACE. A prospective, non-randomised observational trial (HERACLES). (November 2020) - Brunner, T.; Gkika, E.; Bettinger, D.; Schultheiss, M.; Maruschke, L.; Bartl, N.; Kirste, S.; Bamberg, F.; Thimme, R.; Grosu, A.